Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9101-9150 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04654013
PROductivity Study of Presbyopia Elimination in Rural-dwellers III
NAActive, not recruiting
1,291 participants
Started: May 21, 2022 · Completed: Jun 5, 2025
1 condition6 sponsors1 location
NCT05089721
Questionnaire for Obstetricians and Anesthesiologist
N/AActive, not recruiting
200 participants
Started: May 21, 2022 · Completed: Feb 21, 2025
3 conditions1 sponsor1 location
NCT05437939
Adverse Outcomes Following Female Genital Fistula Repair
N/AActive, not recruiting
802 participants
Started: May 20, 2022 · Completed: Jul 31, 2026
2 conditions4 sponsors1 location
NCT05387655
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
N/AActive, not recruiting
4,292 participants
Started: May 20, 2022 · Completed: Jun 20, 2027
4 conditions2 sponsors1 location
NCT06020040
Bone Particles Sizes and the Stability of Soft and Hard Tissue in Aesthetic Area
NAActive, not recruiting
50 participants
Started: May 20, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05868486
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
EARLY_PHASE1Active, not recruiting
100 participants
Started: May 20, 2022 · Completed: Nov 19, 2025
2 conditions2 sponsors1 location
NCT05134428
A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0
NAActive, not recruiting
25 participants
Started: May 20, 2022 · Completed: Feb 20, 2026
2 conditions1 sponsor3 locations
NCT05312411
A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
PHASE1Active, not recruiting
21 participants
Started: May 20, 2022 · Completed: May 31, 2040
1 condition2 sponsors1 location
NCT05339685
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors
PHASE1Active, not recruiting
82 participants
Started: May 20, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors10 locations
NCT06094140
NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer
PHASE2Active, not recruiting
20 participants
Started: May 20, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors3 locations
NCT04981977
Enhancing the Care Transitions Intervention With Peer Support to Reduce Disparities
NAActive, not recruiting
483 participants
Started: May 19, 2022 · Completed: Jul 31, 2025
1 condition5 sponsors1 location
NCT05040386
Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT
NAActive, not recruiting
60 participants
Started: May 19, 2022 · Completed: Oct 1, 2025
1 condition2 sponsors1 location
NCT06794957
A Study of AL8326 in Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
158 participants
Started: May 19, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor10 locations
NCT05445726
ECG Validation Study
PHASE2Active, not recruiting
141 participants
Started: May 19, 2022 · Completed: Nov 1, 2023
1 condition2 sponsors1 location
NCT05123703
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)
PHASE3Active, not recruiting
188 participants
Started: May 19, 2022 · Completed: Sep 17, 2029
1 condition2 sponsors105 locations
NCT05576272
A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
PHASE2/PHASE3Active, not recruiting
460 participants
Started: May 19, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05293249
dMAbs for Prevention of COVID-19
PHASE1Active, not recruiting
61 participants
Started: May 19, 2022 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05366530
Specific Electrophenotypes in Atrial Fibrillation
N/AActive, not recruiting
300 participants
Started: May 19, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05356169
Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia
PHASE2/PHASE3Active, not recruiting
312 participants
Started: May 19, 2022 · Completed: Oct 15, 2027
1 condition1 sponsor1 location
NCT05348317
Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders
NAActive, not recruiting
25 participants
Started: May 19, 2022 · Completed: Sep 30, 2026
4 conditions2 sponsors1 location
NCT05275777
A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
66 participants
Started: May 19, 2022 · Completed: Feb 28, 2030
2 conditions2 sponsors1 location
NCT05293964
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
PHASE1Active, not recruiting
214 participants
Started: May 18, 2022 · Completed: Sep 8, 2025
1 condition2 sponsors1 location
NCT05200481
Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK)
PHASE2Active, not recruiting
110 participants
Started: May 18, 2022 · Completed: Oct 31, 2028
2 conditions1 sponsor29 locations
NCT05258357
Landmark vs. Ultrasound-Assisted Bone Marrow Biopsy Procedure Study
NAActive, not recruiting
100 participants
Started: May 18, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT04634578
Bevacizumab Treatment For Type 1 ROP
PHASE2Active, not recruiting
77 participants
Started: May 18, 2022 · Completed: Jul 31, 2027
1 condition3 sponsors26 locations
NCT05081128
Efficacy in iNPH Shunting (PENS) Trial
NAActive, not recruiting
100 participants
Started: May 18, 2022 · Completed: Aug 31, 2027
1 condition2 sponsors17 locations
NCT05877352
Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial
NAActive, not recruiting
31 participants
Started: May 18, 2022 · Completed: Jul 25, 2025
2 conditions4 sponsors1 location
NCT04898829
Evaluation of PKU Explore France
NAActive, not recruiting
7 participants
Started: May 18, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06452381
Allergenicity Assessment of Green Marine Macroalga Ulva sp.
N/AActive, not recruiting
120 participants
Started: May 18, 2022 · Completed: Mar 9, 2025
1 condition2 sponsors1 location
NCT05141604
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
NAActive, not recruiting
15 participants
Started: May 17, 2022 · Completed: May 31, 2025
6 conditions2 sponsors1 location
NCT05322577
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
PHASE1/PHASE2Active, not recruiting
72 participants
Started: May 17, 2022 · Completed: Mar 12, 2028
2 conditions1 sponsor42 locations
NCT05247164
EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients
NAActive, not recruiting
70 participants
Started: May 17, 2022 · Completed: Mar 31, 2027
2 conditions1 sponsor1 location
NCT05353257
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
PHASE3Active, not recruiting
511 participants
Started: May 17, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor129 locations
NCT05308654
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
PHASE1Active, not recruiting
34 participants
Started: May 17, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor21 locations
NCT05155254
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)
PHASE3Active, not recruiting
407 participants
Started: May 17, 2022 · Completed: Sep 30, 2027
2 conditions3 sponsors112 locations
NCT05327946
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated
PHASE1Active, not recruiting
36 participants
Started: May 17, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor5 locations
NCT05365828
Legacies and Futures: Measuring Roles of Resilience and Vulnerability in Pregnancy and Birth Outcomes
N/AActive, not recruiting
945 participants
Started: May 17, 2022 · Completed: Sep 30, 2025
1 condition17 sponsors14 locations
NCT06728995
Renal Function Prediction in Living Donor Transplant Using Baseline Data
N/AActive, not recruiting
3,500 participants
Started: May 17, 2022 · Completed: Apr 24, 2025
2 conditions1 sponsor1 location
NCT05029960
Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas
EARLY_PHASE1Active, not recruiting
30 participants
Started: May 17, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05246670
PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy
PHASE2Active, not recruiting
88 participants
Started: May 16, 2022 · Completed: Feb 28, 2026
3 conditions2 sponsors10 locations
NCT05484999
The Maternal Well-Being Study
NAActive, not recruiting
84 participants
Started: May 16, 2022 · Completed: May 30, 2025
4 conditions1 sponsor1 location
NCT05374512
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
PHASE3Active, not recruiting
644 participants
Started: May 16, 2022 · Completed: Dec 3, 2025
1 condition2 sponsors227 locations
NCT05233072
Prognostic Impact of Neopterin on Resumption of Walking After a Fracture of the Upper Neck of the Femur in the Elderly
NAActive, not recruiting
150 participants
Started: May 16, 2022 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT05334420
Efficacy Trial Healthy Dads, Healthy Kids for Hispanic Fathers and Children
NAActive, not recruiting
187 participants
Started: May 16, 2022 · Completed: Aug 31, 2026
4 conditions4 sponsors1 location
NCT05299164
GVM±R in Patients With Relapsed or Refractory Aggressive NHL
PHASE1Active, not recruiting
18 participants
Started: May 15, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05412693
Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures
NAActive, not recruiting
110 participants
Started: May 15, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT06021509
Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation
NAActive, not recruiting
102 participants
Started: May 15, 2022 · Completed: Jun 25, 2028
1 condition1 sponsor1 location
NCT05384951
HMB Cerebral Palsy Pilot Study
NAActive, not recruiting
7 participants
Started: May 15, 2022 · Completed: May 31, 2024
1 condition3 sponsors1 location
NCT05177068
Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer
PHASE2Active, not recruiting
42 participants
Started: May 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05206695
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
NAActive, not recruiting
3,840 participants
Started: May 13, 2022 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location